The Dual Chamber Prefilled Syringes Market size was USD 154.21 million in 2022 and is expected to Reach USD 268.56 million by 2030 and grow at a CAGR of 7.08 % over the forecast period of 2023-2030.
In recent years, the market for dual-chamber prefilled syringes has grown and changed significantly. Healthcare professionals and patients will find these innovative syringes to be very practical and effective because they are built with two compartments that can store and deliver two different medications or components in a single injection.
The rise in chronic diseases and the demand for precise and practical drug administration are two major factors driving the market for dual-chamber prefilled syringes. These syringes make it possible to combine and administer two medications that must be administered together at the same time, doing away with the need for manual mixing or separate injections. In addition to saving time, this lowers the possibility of medication errors, making them especially useful in critical care settings.
Dual chamber prefilled syringes have a number of advantages over conventional syringes. They guarantee the potency and effectiveness of sensitive medications by maintaining the two components separate up until the point of administration. Additionally, they facilitate patient compliance by streamlining complicated dosing regimens and minimizing the number of required injections.
Geographically, the market is expanding in many areas, with North America and Europe taking the lead. These areas have well-established healthcare systems, benevolent reimbursement practices, and a high rate of uptake of cutting-edge medical technologies. However, due to rising healthcare costs and increased awareness of dual-chamber prefilled syringes, emerging economies in the Asia Pacific and Latin America are also anticipated to experience rapid market growth.
KEY DRIVERS:
Increasing Prevalence of Chronic Diseases
Drug administration needs to be done frequently and accurately due to the rise in chronic diseases like diabetes, cardiovascular problems, and autoimmune diseases. In order to meet the needs of patients with complex treatment regimens, dual-chamber prefilled syringes offer a practical way to deliver multiple medications or components in a single injection.
Increasing Healthcare Expenditure in Emerging Economies.
RESTRAIN:
Technical Challenges
There are chances of cross-contamination of two different medicine which can cause dangerous effects. Due to manufacturing defects, this can happen. For safety purposes, high-quality safety equipment needs to be used.
Increase in cost of the product.
OPPORTUNITY:
Making cost-effective dual-chamber prefilled syringes
The raw material used for the production at present is costly. Using plastic and glass as substitute reduce the cost of production. This will help make a cost-effective product and also plastic can be recycled.
Growing Geriatric Population
CHALLENGES:
Counterfeiting of products
Many pharmaceutical products are getting counterfeited, which is creating a major challenge for the growth of the industry. There is a delay in the coming of new products into the market because it has to go through many health tests and regulations. Till that time falsified products can be seen in the market.
Changing healthcare policies.
Russia and Ukraine are major suppliers of crude oil, natural gas, and specific metals used to manufacture hospital equipment. As U. S relies on the supply of common raw materials for the healthcare industry, an increase in the cost of medical supplies is conceivable. 11.5 % of the world's oil and 16 % of its natural gas supply are produced by Russia. There may be production hiccups, which could have a direct impact on the plastics supply chain and price globally.
Europe will have to scramble to find new suppliers once the invasion disrupts the supply chain. In turn, this will have a greater impact on natural gas prices. Producers who purchase the raw materials will be able to increase their prices to cover the costs. The impact will nevertheless be felt by healthcare facilities as well as their patients.
The COVID-19 pandemic is projected to increase the size of the global pharmaceutical packaging market from USD 900.2 billion in 2019 to USD 1000.6 billion by 2021, with a Compound Annual Growth Rate (CAGR) of 5.2% as the most likely outcome during the estimated time frame and the worst-case scenario reflecting a 2.1 % CAGR growth. The increased interest in packaging for FMCG and pharmaceutical products, as well as rising web-based business sales as a result of the lockdown, are major drivers for the packaging industry. Every segment of the packaging industry is affected by the coronavirus, which has both benefits and drawbacks.
However, the supply chain was the major problem during the covid-19. There was a 40 % rise in global prefilled syringe market due to vaccination happening globally.
Overall, Covid-19 gave boost to the global Dual Chamber Prefilled Syringes.
By Raw Material
Plastic
Glass
By Application
Industrial Pharmacy
Hospital Pharmacy
.png)
Due to factors like the high preference of healthcare professionals for prefilled injectable devices in order to reduce needle-related injuries, Europe held the largest share of the prefilled syringes market in 2021 with a share of 36.51 %.
Due to the development of rapidly expanding economies and the existence of a sizable untapped market, Asia Pacific is anticipated to experience the highest CAGR during the forecast period. The region's market is anticipated to grow as a result of favorable demographic factors like the large population and rising prevalence of different chronic diseases. The developed prefilled syringes market is represented by nations like China. Ischemic heart disease, stroke, chronic obstructive pulmonary disease (COPD), and type 2 diabetes are the most common chronic NCDs in China among adults aged 60, according to Front Public Health in 2020.
On the other hand, nations like Japan and India offer significant growth potential by luring key market participants with rising foreign direct investment (FDI) as well as product demand.
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
South Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of the Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin American
Some major key players in the Dual Chamber Prefilled Syringes Market are Nipro Corporation, Pfizer Inc, Credence MedSystems Inc, Biosciences Inc, SCHOTT AG, Arte Corporation, Otsuka America Pharmaceutical Inc, AstraZeneca plc, AbbVie Inc, Ypsomed AG, and other players.
A Gx RTF ClearJect COP needle syringe, 1.0-mL luer lock, has been added to Gerresheimer's lineup of prefill able polymer syringes for sensitive biologics, biosimilars, and bio betters.
One silicone-free option combines ImproJect plungers from W.L. Gore & Associates with syriQ BioPure silicone-free syringes from SCHOTT.
| Report Attributes | Details |
| Market Size in 2022 | US$ 154.21 Mn |
| Market Size by 2030 | US$ 268.56 Mn |
| CAGR | CAGR of 7.08 % From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Raw Material (Plastic, Glass) • By Application (Industrial Pharmacy, Hospital Pharmacy) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Nipro Corporation, Pfizer Inc, Credence MedSystems Inc, Biosciences Inc, SCHOTT AG, Arte Corporation, Otsuka America Pharmaceutical Inc, AstraZeneca plc, AbbVie Inc, Ypsomed AG, and other players. |
| Key Drivers | • Increasing Prevalence of Chronic Diseases • Increasing Healthcare Expenditure in Emerging Economies. |
| Market Opportunities | • Making cost-effective dual-chamber prefilled syringes • Growing Geriatric Population |
Ans: The Dual Chamber Prefilled Syringes Market is expected to grow at a CAGR of 7.08 % over the forecast period of 2023-2030.
Ans: The Dual Chamber Prefilled Syringes Market size was USD 154.21 million in 2022 and is expected to Reach USD 268.56 million by 2030 and grow at a CAGR of 7.08 % over the forecast period of 2023-2030.
Ans: Europe held the largest share of the prefilled syringes market in 2021 with a share of 36.51 %.
Ans: Increasing the Prevalence of Chronic Diseases is a major key driver for the growth of the Dual Chamber Prefilled Syringes Market.
Ans: Technical Challenges faced during production is major restrain.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of Russia and Ukraine War
4.2 Impact of Covid 19
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Dual Chamber Prefilled Syringes Diagnostics Market Segmentation, By Raw Material
8.1 lastic
8.2 Glass
9. Dual Chamber Prefilled Syringes Diagnostics Market Segmentation By Application
9.1 Industrial Pharmacy
9.2 Hospital Pharmacy
10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 North America Dual Chamber Prefilled Syringes Diagnostics Market by Country
10.2.2North America Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.2.3 North America Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.2.4 USA
10.2.4.1 USA Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.2.4.2 USA Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.2.7 Canada
10.2.7.1 Canada Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.2.7.2 Canada Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.2.8 Mexico
10.2.8.1 Mexico Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.2.8.2 Mexico Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.3 Europe
10.3.1 Europe Dual Chamber Prefilled Syringes Diagnostics Market by Country
1.3.3.2 Europe Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.3.3 Europe Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.3.6 Germany
10.3.6.1 Germany Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.3.6.2 Germany Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.3.7 UK
10.3.7.1 UK Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.3.7.2 UK Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.3.8 France
10.3.8.1 France Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.3.8.2 France Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.3.9 Italy
10.3.9.1 Italy Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.3.9.2 Italy Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.3.10 Spain
10.3.10.1 Spain Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.3.10.2 Spain Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.3.11 The Netherlands
10.3.11.1 Netherlands Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.3.11.2 Netherlands Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.3.11 Rest of Europe
10.3.11.1 Rest of Europe Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.3.11.2 Rest of Europe Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.4 Asia-Pacific
10.4.1 Asia Pacific Dual Chamber Prefilled Syringes Diagnostics Market by Country
10.4.2 Asia Pacific Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.4.3 Asia Pacific Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.4.6 Japan
10.4.6.1 Japan Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.4.6.2 Japan Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.4.7 South Korea
10.4.7.1 South Korea Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.4.7.2 South Korea Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.4.8 China
10.4.8.1 China Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.4.8.2 China Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.4.9 India
10.4.9.1 India Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.4.9.2 India Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.4.10 Australia
10.4.10.1 Australia Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.4.10.2 Australia Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.4.11 Rest of Asia-Pacific
10.4.11.1 APAC Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.4.11.2 APAC Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.5 The Middle East & Africa
10.5.1 The Middle East & Africa Dual Chamber Prefilled Syringes Diagnostics Market by Country
10.5.2 The Middle East & Africa Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.5.3 The Middle East & Africa Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.5.6 Israel
10.5.6.1 Israel Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.5.6.2 Israel Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.5.7 UAE
10.5.7.1 UAE Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.5.7.2 UAE Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.5.8 South Africa
10.5.8.1 South Africa Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.5.8.2 South Africa Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.5.9 Rest of Middle East & Africa
10.5.9.1 Rest of Middle East & Asia Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.5.9.2 Rest of Middle East & Asia Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.6 Latin America
10.6.1 Latin America Dual Chamber Prefilled Syringes Diagnostics Market by Country
10.6.2 Latin America Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.6.3 Latin America Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.6.6 Brazil
10.6.6.1 Brazil Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.6.6.2 Brazil Africa Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.6.7 Argentina
10.6.7.1 Argentina Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.6.7.2 Argentina Dual Chamber Prefilled Syringes Diagnostics Market by Application
10.6.8 Rest of Latin America
10.6.8.1 Rest of Latin America Dual Chamber Prefilled Syringes Diagnostics Market by Raw Material
10.6.8.2 Rest of Latin America Dual Chamber Prefilled Syringes Diagnostics Market by Application
11. Company profile
11.1 Nipro Corporation
11.1.1 Market Overview
11.1.2 Financials
11.1.3 Product/Services/Offerings
11.1.4 SWOT Analysis
11.1.5 The SNS View
11.2 Pfizer Inc
11.2.1 Market Overview
11.2.2 Financials
11.2.3 Product/Services/Offerings
11.2.4 SWOT Analysis
11.2.5 The SNS View
11.3 , Credence MedSystems Inc
11.3.1 Market Overview
11.3.2 Financials
11.3.3 Product/Services/Offerings
11.3.4 SWOT Analysis
11.3.5 The SNS View
11.4 Biosciences Inc
11.4.1 Market Overview
11.4.2 Financials
11.4.3 Product/Services/Offerings
11.4.4 SWOT Analysis
11.4.5 The SNS View
11.5 SCHOTT AG
11.5.1 Market Overview
11.5.2 Financials
11.5.3 Product/Services/Offerings
11.5.4 SWOT Analysis
11.5.5 The SNS View
11.6 Arte Corporation
11.6.1 Market Overview
11.6.2 Financials
11.6.3 Product/Services/Offerings
11.6.4 SWOT Analysis
11.6.5 The SNS View
11.7 Otsuka America Pharmaceutical Inc
11.7.1 Market Overview
11.7.2 Financials
11.7.3 Product/Services/Offerings
11.7.4 SWOT Analysis
11.7.5 The SNS View
11.8 AstraZeneca plc
11.8.1 Market Overview
11.8.2 Financials
11.8.3 Product/Services/Offerings
11.8.4 SWOT Analysis
11.8.5 The SNS View
11.9 AbbVie Inc
11.9.1 Market Overview
11.9.2 Financials
11.9.3 Product/Services/Offerings
11.9.4 SWOT Analysis
11.9.5 The SNS View
11.10 Ypsomed AG
11.10.1 Market Overview
11.10.2 Financials
11.10.3 Product/Services/Offerings
11.10.4 SWOT Analysis
11.10.5 The SNS View
12. Competitive Landscape
12.1 Competitive Benchmarking
12.2 Market Share Analysis
12.3 Recent Developments
13. Used Cases and Best Practices
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Hospital EMR Systems Market Size was valued at USD 16.53 billion in 2022, and is expected to reach USD 30.84 billion by 2030, and grow at a CAGR of 8.1% over the forecast period 2023-2030.
The Infection Surveillance Solutions Market Size was assessed at USD 616.08 million in 2022, and is predicted to increase at a CAGR of 15.2% from 2023 to 2030 and to reach USD 1911 million by 2030.
The PET-CT Scanner Device Market size was estimated USD 2.3 billion in 2022 and is expected to reach USD 4.0 billion by 2030 at a CAGR of 7.2% during the forecast period of 2023-2030.
The Pharmaceutical Excipients Market Size was valued at USD 9.09 billion in 2023 and is expected to reach USD 14.52 billion by 2031, and grow at a CAGR of 6.02% over the forecast period 2024-2031.
The Interactive Patient Engagement Solutions Market size was assessed at USD 151.18 billion by 2022, and is supposed to arrive at USD 538.19 billion by 2030 and develop at a CAGR of 17.2% over the forecast period 2023-2030.
The Multiple Sclerosis (MS) Market size was valued at USD 23.2 billion in 2022 and is expected to reach USD 28.21 billion by 2030 and grow at a CAGR of 2.2% over the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
